Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Paclitaxel in Gastric Adenocarcinoma and Carcinomatosis
NCT05977998Phase 2Recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2023
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in gastric adenocarcinoma, gastroesophageal junction cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Sep 2023; status: recruiting.
02
Drugs
paclitaxel
03
Conditions
gastric adenocarcinomagastroesophageal junction cancer
Beyond the preview
Go deeper on NCT05977998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05977998.